Squarepoint Ops »

Cidara Therapeutics shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2025-12-31 $65M 294k 220.89

More positions owned by Squarepoint Ops

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Apple (AAPL)
Advanced Micro Devices (AMD)
Tesla Motors (TSLA)
Broadcom (AVGO)
Ishares Tr Msci Emg Mkt Etf Put Option (EEM)
Ishares Tr Russell 2000 Etf (IWM)
Vaneck Etf Trust Semiconductr Etf (SMH)

View all positions for Squarepoint Ops

Top funds holding Cidara Therapeutics

RA Capital Management
Vanguard Group
BlackRock
BVF
UBS Group
Darwin Global Management
Vivo Capital
State Street Corporation
Susquehanna International
FMR
Leucadia National Corporation
Paradigm Biocapital Advisors
Citadel Advisors
Henderson Group
Glazer Capital

View all funds holding Cidara Therapeutics